Study of Fluoxetine in Patients With Depersonalization Disorder - Related Studies

Study of Fluoxetine in Patients With Depersonalization Disorder

This study has been completed.

Study NCT00004446. Last updated on June 23, 2005. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Depersonalization Disorder

2	Additional conditions recognized in this trial
		Depersonalization
		Disease

3	More general conditions related to this trial
		Behavioral Symptoms
		Pathologic Processes

4	Interventions listed in this trial
		fluoxetine

5	More general drug interventions related to this trial
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Central Nervous System Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)
		Mount Sinai School of Medicine